{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-145738","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.630765+00:00","generated_at":"2026-05-18T22:25:17.869182+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NeuroPace names Patrick Williams as CFO; Rebecca Kuhn departs after 25 years","bullets":["Rebecca Kuhn stepped down as CFO on June 20, 2025; will serve as Senior Strategic Advisor through June 19, 2026.","Kuhn receives 12 months base salary severance, 18 months COBRA, $88,885 pro-rated bonus, and continued equity vesting.","Patrick F. Williams appointed CFO effective June 20; previously CFO at STAAR Surgical (2024 net sales >$300M).","Williams' base salary $500,000, target bonus 60%, plus equity awards: 51,850 RSUs and 87,950 options with 4-year vest.","CEO Joel Becker noted Williams' experience scaling medical device companies; thanked Kuhn for 25-year tenure."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-145738","json":"https://secwatch.observer/filing/0001193125-25-145738.json","markdown":"https://secwatch.observer/filing/0001193125-25-145738.md","text":"https://secwatch.observer/filing/0001193125-25-145738.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000119312525145738/0001193125-25-145738-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000119312525145738/d941443d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:25:17.869182+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"50d5013fd0","claim":"Patrick F. Williams was appointed as Chief Financial Officer at NeuroPace Inc.","evidence_excerpt":"the Company has appointed Patrick F. Williams as Chief Financial Officer, effective as of the Transition Date.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312525145738/0001193125-25-145738-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"8788933df9","claim":"Rebecca Kuhn resigned as Chief Financial Officer at NeuroPace Inc.","evidence_excerpt":"On June 20, 2025, Rebecca Kuhn departed from her position as Chief Financial Officer and Vice President, Finance and Administration of NeuroPace, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1528287/000119312525145738/0001193125-25-145738-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}